Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9951-10000 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05007470
Alcoholic Liver Disease and the Gut Microbiome
NAActive, not recruiting
80 participants
Started: Jan 31, 2022 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
N/AActive, not recruiting
72 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2027
7 conditions1 sponsor6 locations
NCT05203445
A Study of Olaparib and Pembrolizumab in People with Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
PHASE2Active, not recruiting
23 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors7 locations
NCT05160636
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
N/AActive, not recruiting
999 participants
Started: Jan 31, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT05153941
Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures
N/AActive, not recruiting
3,500 participants
Started: Jan 31, 2022 · Completed: Jan 31, 2030
2 conditions3 sponsors1 location
NCT06514287
Telehealth Interventions for Daily Routine Activities in Children and Adolescents With Disabilities
NAActive, not recruiting
21 participants
Started: Jan 31, 2022 · Completed: Oct 25, 2024
2 conditions1 sponsor1 location
NCT05228145
Gene Therapy Study for Children With CLN5 Batten Disease
PHASE1/PHASE2Active, not recruiting
6 participants
Started: Jan 31, 2022 · Completed: Nov 30, 2028
1 condition1 sponsor2 locations
NCT05241951
Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities
NAActive, not recruiting
5,760 participants
Started: Jan 31, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05199389
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy
NAActive, not recruiting
60 participants
Started: Jan 31, 2022 · Completed: Nov 10, 2028
1 condition1 sponsor1 location
NCT05176223
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
PHASE2Active, not recruiting
30 participants
Started: Jan 30, 2022 · Completed: Nov 30, 2027
4 conditions1 sponsor1 location
NCT05171972
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
N/AActive, not recruiting
40 participants
Started: Jan 29, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06329466
The Effect of Emotional Freedom Technique (EFT) on Pain Intensity and Menstruation Symptoms
N/AActive, not recruiting
48 participants
Started: Jan 28, 2022 · Completed: Jul 25, 2024
1 condition2 sponsors1 location
NCT05065294
Psilocybin Therapy for Depression in Bipolar II Disorder
PHASE2Active, not recruiting
14 participants
Started: Jan 28, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06945731
The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Weight Loss in Overweight and Obese Patients
NAActive, not recruiting
50 participants
Started: Jan 28, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT05362903
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
N/AActive, not recruiting
1,854 participants
Started: Jan 28, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor122 locations
NCT05064865
Impact of Regular Consumption of Grapes on Eye Health in Singapore Older Adults
NAActive, not recruiting
34 participants
Started: Jan 28, 2022 · Completed: Oct 31, 2024
2 conditions3 sponsors1 location
NCT04980833
Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
PHASE2Active, not recruiting
41 participants
Started: Jan 27, 2022 · Completed: Jul 22, 2027
1 condition1 sponsor6 locations
NCT05241392
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PHASE1Active, not recruiting
30 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05165446
Novel MRE Technique to Assess a Risk Factor for Liver Cancer
N/AActive, not recruiting
35 participants
Started: Jan 27, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05898711
Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
N/AActive, not recruiting
200 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2026
1 condition1 sponsor1 location
NCT05318183
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
NAActive, not recruiting
65 participants
Started: Jan 27, 2022 · Completed: May 30, 2026
4 conditions2 sponsors1 location
NCT05194345
An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD
NAActive, not recruiting
51 participants
Started: Jan 27, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT04823624
MBG453 in Lower Risk MDS
PHASE2Active, not recruiting
20 participants
Started: Jan 27, 2022 · Completed: Nov 1, 2026
1 condition2 sponsors3 locations
NCT05156268
A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
PHASE2Active, not recruiting
26 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors7 locations
NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Jan 27, 2022 · Completed: May 31, 2025
4 conditions1 sponsor20 locations
NCT05251259
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
PHASE2Active, not recruiting
622 participants
Started: Jan 27, 2022 · Completed: Jan 29, 2026
1 condition1 sponsor267 locations
NCT05338060
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
N/AActive, not recruiting
10 participants
Started: Jan 26, 2022 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT05171491
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
N/AActive, not recruiting
425 participants
Started: Jan 26, 2022 · Completed: Sep 2, 2024
2 conditions1 sponsor12 locations
NCT05681325
Evaluation of Antioxidant and Anti-inflammatory Effect of Matcha Tea Intake on Periodontal Health
NAActive, not recruiting
40 participants
Started: Jan 25, 2022 · Completed: Jul 12, 2024
1 condition1 sponsor1 location
NCT05084638
Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.
PHASE4Active, not recruiting
180 participants
Started: Jan 25, 2022 · Completed: Feb 16, 2026
1 condition1 sponsor36 locations
NCT05161494
Gait in Rare Diseases
N/AActive, not recruiting
70 participants
Started: Jan 25, 2022 · Completed: Jan 30, 2026
2 conditions2 sponsors1 location
NCT04925544
Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
PHASE2Active, not recruiting
13 participants
Started: Jan 25, 2022 · Completed: Jun 17, 2027
2 conditions3 sponsors1 location
NCT05315206
Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution
NAActive, not recruiting
29 participants
Started: Jan 25, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor2 locations
NCT05136677
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
PHASE2Active, not recruiting
100 participants
Started: Jan 25, 2022 · Completed: Oct 8, 2026
1 condition1 sponsor21 locations
NCT04919824
Monopolar Current Cutting Knife vs Bipolar RFA Knife
NAActive, not recruiting
80 participants
Started: Jan 25, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor2 locations
NCT05253846
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
PHASE2Active, not recruiting
63 participants
Started: Jan 25, 2022 · Completed: Oct 30, 2028
1 condition1 sponsor1 location
NCT04564898
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
PHASE1/PHASE2Active, not recruiting
48 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06576050
WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise
N/AActive, not recruiting
21 participants
Started: Jan 25, 2022 · Completed: Nov 1, 2024
4 conditions2 sponsors1 location
NCT05104853
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Jan 25, 2022 · Completed: Jan 30, 2026
1 condition1 sponsor19 locations
NCT04929392
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
PHASE2Active, not recruiting
3 participants
Started: Jan 25, 2022 · Completed: Apr 25, 2027
19 conditions2 sponsors1 location
NCT05189457
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
PHASE2Active, not recruiting
32 participants
Started: Jan 25, 2022 · Completed: Jul 31, 2028
2 conditions2 sponsors1 location
NCT05184712
Phase 3 Clinical Study of AK112 for NSCLC Patients
PHASE3Active, not recruiting
322 participants
Started: Jan 25, 2022 · Completed: Nov 2, 2025
1 condition1 sponsor1 location
NCT05256238
Effect of Exercise in Head and Neck Cancer Patients
NAActive, not recruiting
150 participants
Started: Jan 25, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05971862
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
36 participants
Started: Jan 25, 2022 · Completed: Oct 4, 2024
1 condition1 sponsor3 locations
NCT05203939
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jan 24, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor7 locations
NCT06279897
LBNP Tolerance With Skin Warming After Exercise Cold Stress
NAActive, not recruiting
10 participants
Started: Jan 24, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT04966676
Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer
PHASE2Active, not recruiting
5 participants
Started: Jan 24, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT04590417
Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women
NAActive, not recruiting
20 participants
Started: Jan 24, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05168826
China S3 PMS: SAPIEN 3 China Post Market Registry Study
N/AActive, not recruiting
250 participants
Started: Jan 24, 2022 · Completed: Dec 31, 2035
1 condition1 sponsor14 locations
NCT04593680
Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men
NAActive, not recruiting
20 participants
Started: Jan 24, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor1 location